Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results for the quarter ended June 30, 2013.
“The FDA has made it a priority to help drug developers address the global health crisis posed by multi-drug resistant infections, particularly difficult-to-treat serious and life-threatening Gram-negative infections, through designations like QIDP, which our lead candidate eravacycline was recently awarded,” said Guy Macdonald, Tetraphase President and Chief Executive Officer.
Hey, check out all the research scientist jobs. Post your resume today!
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results for the quarter ended June 30, 2013.
“The FDA has made it a priority to help drug developers address the global health crisis posed by multi-drug resistant infections, particularly difficult-to-treat serious and life-threatening Gram-negative infections, through designations like QIDP, which our lead candidate eravacycline was recently awarded,” said Guy Macdonald, Tetraphase President and Chief Executive Officer.
Hey, check out all the research scientist jobs. Post your resume today!
